Collins Stewart Maintains a 'Hold' on Dolby Laboratories (DLB); RIMM Signs Licensing Agreement; Settlement Already Reflected in Guidance
Tweet Send to a Friend
Collins Stewart maintains a 'Hold' on Dolby Laboratories (NYSE: DLB) price target of $45.00.
Collins analyst says, "DLB announced this ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Collins analyst says, "DLB announced this ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
